Literature DB >> 17668424

Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta.

Hao Zhang1, Stephen B Doty, Christine Hughes, David Dempster, Nancy Pleshko Camacho.   

Abstract

The current study addresses whether alterations in osteoclasts (OCs) derived from oim/oim mice, an established model of moderate-to-severe OI, are present. Bone marrow cells from oim/oim and wildtype (+/+) mice were cultured on bone slices in the presence of MCSF and RANKL and evaluated at days 0, 1, 2, 4, and 7. OCs were identified by tartrate-resistant acid phosphatase (TRAP) staining, and bone slice resorption pits were analyzed by reflection microscopy. Flow cytometry was used to examine CD51 (integrin alphaV) and CD61 (integrin beta3) markers. Confocal microscopy was used to assess changes in OC morphology and resorption. There was no difference between the OC precursors of the two genotypes in expression of CD51 and CD61 markers. At day 2, the bone slices seeded with oim/oim cells had a greater percentage of mononuclear cells associated with resorption pits compared to +/+ bone slices. At day 4, the diameter and area of oim/oim OCs were larger compared to the +/+ OCs, and the number of nuclei per OC was also greater for the oim/oim group. At day 7, the oim/oim OCs contained more F-actin rings compared to the +/+ OCs, and the number of OCs in the oim/oim group was greater compared to the +/+ group. The resorbed area of bone slices for the oim/oim group was also greater compared to the +/+ group at day 7. In conclusion, oim/oim mononuclear resorbing cells and OCs showed cellular changes and greater resorptive activity compared to +/+ cells, features that likely contribute to dysregulated bone remodeling in OI. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668424      PMCID: PMC2944034          DOI: 10.1002/jcb.21337

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  38 in total

1.  The material basis for reduced mechanical properties in oim mice bones.

Authors:  N P Camacho; L Hou; T R Toledano; W A Ilg; C F Brayton; C L Raggio; L Root; A L Boskey
Journal:  J Bone Miner Res       Date:  1999-02       Impact factor: 6.741

Review 2.  Osteoclasts, macrophages, and the molecular mechanisms of bone resorption.

Authors:  S L Teitelbaum; M M Tondravi; F P Ross
Journal:  J Leukoc Biol       Date:  1997-04       Impact factor: 4.962

Review 3.  Commitment and differentiation of stem cells to the osteoclast lineage.

Authors:  S Hayashi; T Yamane; A Miyamoto; H Hemmi; H Tagaya; Y Tanio; H Kanda; H Yamazaki; T Kunisada
Journal:  Biochem Cell Biol       Date:  1998       Impact factor: 3.626

4.  Osteogenesis imperfecta: bone turnover, bone density, and ultrasound parameters.

Authors:  C Cepollaro; S Gonnelli; C Pondrelli; A Montagnani; S Martini; D Bruni; C Gennari
Journal:  Calcif Tissue Int       Date:  1999-08       Impact factor: 4.333

5.  Bone histomorphometry in adults with type IA osteogenesis imperfecta.

Authors:  E F McCarthy; K Earnest; K Rossiter; J Shapiro
Journal:  Clin Orthop Relat Res       Date:  1997-03       Impact factor: 4.176

6.  Bone geometry and strength measurements in aging mice with the oim mutation.

Authors:  D J McBride; J R Shapiro; M G Dunn
Journal:  Calcif Tissue Int       Date:  1998-02       Impact factor: 4.333

7.  Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts.

Authors:  I Nakamura; N Takahashi; T Sasaki; E Jimi; T Kurokawa; T Suda
Journal:  J Bone Miner Res       Date:  1996-12       Impact factor: 6.741

8.  Cell biology of Paget's disease.

Authors:  S V Reddy; C Menaa; F R Singer; A Demulder; G D Roodman
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

9.  Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.

Authors:  S Takeda; T Yoshizawa; Y Nagai; H Yamato; S Fukumoto; K Sekine; S Kato; T Matsumoto; T Fujita
Journal:  Endocrinology       Date:  1999-02       Impact factor: 4.736

10.  The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

Authors:  T L Burgess; Y Qian; S Kaufman; B D Ring; G Van; C Capparelli; M Kelley; H Hsu; W J Boyle; C R Dunstan; S Hu; D L Lacey
Journal:  J Cell Biol       Date:  1999-05-03       Impact factor: 10.539

View more
  10 in total

1.  Myostatin deficiency partially rescues the bone phenotype of osteogenesis imperfecta model mice.

Authors:  A K Oestreich; S M Carleton; X Yao; B A Gentry; C E Raw; M Brown; F M Pfeiffer; Y Wang; C L Phillips
Journal:  Osteoporos Int       Date:  2015-07-16       Impact factor: 4.507

2.  Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine.

Authors:  Haitao Li; Xi Jiang; John Delaney; Tiziana Franceschetti; Ines Bilic-Curcic; Judy Kalinovsky; Joseph A Lorenzo; Danka Grcevic; David W Rowe; Ivo Kalajzic
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 3.  Bone composition: relationship to bone fragility and antiosteoporotic drug effects.

Authors:  Adele L Boskey
Journal:  Bonekey Rep       Date:  2013-12-04

4.  Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α.

Authors:  G Brunetti; F Papadia; A Tummolo; R Fischetto; F Nicastro; L Piacente; A Ventura; G Mori; A Oranger; I Gigante; S Colucci; M Ciccarelli; M Grano; L Cavallo; M Delvecchio; M F Faienza
Journal:  Osteoporos Int       Date:  2016-02-08       Impact factor: 4.507

5.  Splenomegaly, myeloid lineage expansion and increased osteoclastogenesis in osteogenesis imperfecta murine.

Authors:  Brya G Matthews; Emilie Roeder; Xi Wang; Hector Leonardo Aguila; Sun-Kyeong Lee; Danka Grcevic; Ivo Kalajzic
Journal:  Bone       Date:  2017-06-07       Impact factor: 4.398

6.  Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors.

Authors:  Thomas E Uveges; Patricia Collin-Osdoby; Wayne A Cabral; Felicia Ledgard; Leah Goldberg; Clemens Bergwitz; Antonella Forlino; Philip Osdoby; Gloria A Gronowicz; Joan C Marini
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

7.  Loss of RANKL in osteocytes dramatically increases cancellous bone mass in the osteogenesis imperfecta mouse (oim).

Authors:  Sarah M Zimmerman; Melissa E Heard-Lipsmeyer; Milena Dimori; Jeff D Thostenson; Erin M Mannen; Charles A O'Brien; Roy Morello
Journal:  Bone Rep       Date:  2018-07-02

8.  Compression Fractures and Partial Phenotype Rescue With a Low Phosphorus Diet in the Chihuahua Zebrafish Osteogenesis Imperfecta Model.

Authors:  Silvia Cotti; Ann Huysseune; Daria Larionova; Wolfgang Koppe; Antonella Forlino; Paul Eckhard Witten
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

9.  Therapeutic impact of low amplitude high frequency whole body vibrations on the osteogenesis imperfecta mouse bone.

Authors:  Maximilien Vanleene; Sandra J Shefelbine
Journal:  Bone       Date:  2013-01-22       Impact factor: 4.398

10.  Insulin receptor substrate-1 time-dependently regulates bone formation by controlling collagen Iα2 expression via miR-342.

Authors:  Yue Guo; Chen-Yi Tang; Xiao-Fei Man; Hao-Neng Tang; Jun Tang; Fang Wang; Ci-La Zhou; Shu-Wen Tan; Yun-Zhi Feng; Hou-De Zhou
Journal:  FASEB J       Date:  2016-09-13       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.